MICHELLE SPARROW: Open Payments
NPI 1184025140 · CRYSTAL LAKE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 21 payments from 12 companies in 2025. Trend: 2023 $612 · 2024 $813 · 2025 $699
Food & beverage: $449Consulting: $250
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $250 |
| Calliditas Therapeutics US Inc. | 5 | $111 |
| Amgen Inc. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Novo Nordisk Inc | 2 | $44 |
| Fresenius USA Marketing, Inc. | 2 | $42 |
| Bard Peripheral Vascular, Inc. | 1 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $26 |
| AKEBIA THERAPEUTICS INC | 1 | $25 |
| Apellis Pharmaceuticals, Inc. | 1 | $24 |
Products named: TARPEYO, KRYSTEXXA, FARXIGA, Ozempic, VELPHORO, WavelinQ, FUROSCIX, Vafseo.
Industry payments across IL — which companies pay providers there.
